Corrigendum to ‘Unusual antigen presentation offers new insight into HIV vaccine design’ [Curr Opin Immunol 46 (2017) 75–81] (Current Opinion in Immunology (2017) 46 (75–81), (S0952791516301583) (10.1016/j.coi.2017.04.009))

Andrew J. McMichael, Louis Picker

Research output: Contribution to journalComment/debate

Abstract

The authors regret omitting to declare a possible conflict of interest: Conflict of interest Dr. Picker and OHSU have a significant financial interest in Vir Biotechnology, Inc, a company that may have a commercial interest in the research and technology reviewed in this paper. The potential individual and institutional conflicts of interest have been reviewed and managed by OHSU. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Number of pages1
JournalCurrent Opinion in Immunology
Volume53
DOIs
StatePublished - Aug 1 2018

Fingerprint

AIDS Vaccines
Conflict of Interest
Antigen Presentation
Allergy and Immunology
Biotechnology
Emotions
Technology
Research
corrigendum

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{cab040203c974600aa1316f372feee38,
title = "Corrigendum to ‘Unusual antigen presentation offers new insight into HIV vaccine design’ [Curr Opin Immunol 46 (2017) 75–81] (Current Opinion in Immunology (2017) 46 (75–81), (S0952791516301583) (10.1016/j.coi.2017.04.009))",
abstract = "The authors regret omitting to declare a possible conflict of interest: Conflict of interest Dr. Picker and OHSU have a significant financial interest in Vir Biotechnology, Inc, a company that may have a commercial interest in the research and technology reviewed in this paper. The potential individual and institutional conflicts of interest have been reviewed and managed by OHSU. The authors would like to apologise for any inconvenience caused.",
author = "McMichael, {Andrew J.} and Louis Picker",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/j.coi.2018.08.006",
language = "English (US)",
volume = "53",
journal = "Current Opinion in Immunology",
issn = "0952-7915",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Corrigendum to ‘Unusual antigen presentation offers new insight into HIV vaccine design’ [Curr Opin Immunol 46 (2017) 75–81] (Current Opinion in Immunology (2017) 46 (75–81), (S0952791516301583) (10.1016/j.coi.2017.04.009))

AU - McMichael, Andrew J.

AU - Picker, Louis

PY - 2018/8/1

Y1 - 2018/8/1

N2 - The authors regret omitting to declare a possible conflict of interest: Conflict of interest Dr. Picker and OHSU have a significant financial interest in Vir Biotechnology, Inc, a company that may have a commercial interest in the research and technology reviewed in this paper. The potential individual and institutional conflicts of interest have been reviewed and managed by OHSU. The authors would like to apologise for any inconvenience caused.

AB - The authors regret omitting to declare a possible conflict of interest: Conflict of interest Dr. Picker and OHSU have a significant financial interest in Vir Biotechnology, Inc, a company that may have a commercial interest in the research and technology reviewed in this paper. The potential individual and institutional conflicts of interest have been reviewed and managed by OHSU. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85053294455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053294455&partnerID=8YFLogxK

U2 - 10.1016/j.coi.2018.08.006

DO - 10.1016/j.coi.2018.08.006

M3 - Comment/debate

C2 - 30220351

AN - SCOPUS:85053294455

VL - 53

JO - Current Opinion in Immunology

JF - Current Opinion in Immunology

SN - 0952-7915

ER -